FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Francis Colpaert

Research Profile

Living Beings

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Peter Heusler; Christiane Palmier; Stéphanie Tardif; Sophie Bernois; Francis C Colpaert; Didier Cussac
[(3)H]-F13640, a novel, selective and high-efficacy serotonin 5-HT(1A) receptor agonist radioligand.
Kristof Deseure; Sophie Bréand; Francis C Colpaert
Curative-like analgesia in a neuropathic pain model: parametric analysis of the dose and the duration of treatment with a high-efficacy 5-HT(1A) receptor agonist.
Francis C Colpaert; Kristof Deseure; Luis Stinus; Hugo Adriaensen
High-efficacy 5-hydroxytryptamine 1A receptor activation counteracts opioid hyperallodynia and affective conditioning.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Francis Colpaert (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Peter Heusler; Christiane Palmier; Stéphanie Tardif; Sophie Bernois; Francis C Colpaert; Didier Cussac
[(3)H]-F13640, a novel, selective and high-efficacy serotonin 5-HT(1A) receptor agonist radioligand.
Naunyn-Schmiedeberg's archives of pharmacology 2010;382(4):321-30.
2007: Kristof Deseure; Sophie Bréand; Francis C Colpaert
Curative-like analgesia in a neuropathic pain model: parametric analysis of the dose and the duration of treatment with a high-efficacy 5-HT(1A) receptor agonist.
European journal of pharmacology 2007;568(1-3):134-41.
2006: Francis C Colpaert; Kristof Deseure; Luis Stinus; Hugo Adriaensen
High-efficacy 5-hydroxytryptamine 1A receptor activation counteracts opioid hyperallodynia and affective conditioning.
The Journal of pharmacology and experimental therapeutics 2006;316(2):892-9.
2005: Peter Heusler; Petrus J Pauwels; Thierry Wurch; Adrian Newman-Tancredi; Jan Tytgat; Francis C Colpaert; Didier Cussac
Differential ion current activation by human 5-HT(1A) receptors in Xenopus oocytes: evidence for agonist-directed trafficking of receptor signalling.
Neuropharmacology 2005;49(7):963-76.
2005: Ivan Kiss; Anne-Dominique Degryse; Laurent Bardin; Ignacio Alvarez Gomez de Segura; Francis C Colpaert
The novel analgesic, F 13640, produces intra- and postoperative analgesia in a rat model of surgical pain.
European journal of pharmacology 2005;523(1-3):29-39.
2005: Laurent Bardin; Marie-Bernadette Assié; Martine Pélissou; Isabelle Royer-Urios; Adrian Newman-Tancredi; Jean-Paul Ribet; François Sautel; Wouter Koek; Francis C Colpaert
Dual, hyperalgesic, and analgesic effects of the high-efficacy 5-hydroxytryptamine 1A (5-HT1A) agonist F 13640 [(3-chloro-4-fluoro-phenyl)-[4-fluoro-4-{[(5-methyl-pyridin-2-ylmethyl)-amino]-methyl}piperidin-1-yl]methanone, fumaric acid salt]: relationship with 5-HT1A receptor occupancy and kinetic parameters.
The Journal of pharmacology and experimental therapeutics 2005;312(3):1034-42.
2004: Kristof Deseure; Hugo Adriaensen; Francis C Colpaert
Effects of the combined continuous administration of morphine and the high-efficacy 5-HT1A agonist, F 13640 in a rat model of trigeminal neuropathic pain.
European journal of pain (London, England) 2004;8(6):547-54.
2004: Francis C Colpaert; Wei-Ping Wu; Jing-Xia Hao; Isabelle Royer; François Sautel; Zsuzsanna Wiesenfeld-Hallin; Xiao-Jun Xu
High-efficacy 5-HT1A receptor activation causes a curative-like action on allodynia in rats with spinal cord injury.
European journal of pharmacology 2004;497(1):29-33.
2004: Laurent Bardin; Francis C Colpaert
Role of spinal 5-HT(1A) receptors in morphine analgesia and tolerance in rats.
European journal of pain (London, England) 2004;8(3):253-61.
2004: Yves Rival; Nathalie Benéteau; Violaine Chapuis; Thierry Taillandier; Fabrice Lestienne; Elisabeth Dupont-Passelaigue; Jean-François Patoiseau; Francis C Colpaert; Didier Junquéro
Cardiovascular drugs inhibit MMP-9 activity from human THP-1 macrophages.
DNA and cell biology 2004;23(5):283-92.
2004: Marc Marien; Francis C Colpaert; Alan C Rosenquist
Noradrenergic mechanisms in neurodegenerative diseases: a theory.
Brain research. Brain research reviews 2004;45(1):38-78.
2004: Eric P M Prinssen; Francis C Colpaert; Mark S Kleven; Wouter Koek
Ability of dopamine antagonists to inhibit the locomotor effects of cocaine in sensitized and non-sensitized C57BL/6 mice depends on the challenge dose.
Psychopharmacology 2004;172(4):409-14.
2004: Gareth W John; Robert Létienne; Bruno Le Grand; Christophe Pignier; Bernard Vacher; Jean-Francois Patoiseau; Francis C Colpaert; Alain Coulombe
KC 12291: an atypical sodium channel blocker with myocardial antiischemic properties.
Cardiovascular drug reviews 2004;22(1):17-26.
2004: Philippe Chopin; Thomas Debeir; Rita Raisman-Vozari; Francis C Colpaert; Marc Marien
Protective effect of the alpha2-adrenoceptor antagonist, dexefaroxan, against spatial memory deficit induced by cortical devascularization in the adult rat.
Experimental neurology 2004;185(1):198-200.
2003: Wei-Ping Wu; Jing-Xia Hao; Xiao-Jun Xu; Zsuzsanna Wiesenfeld-Hallin; Wouter Koek; Francis C Colpaert
The very-high-efficacy 5-HT1A receptor agonist, F 13640, preempts the development of allodynia-like behaviors in rats with spinal cord injury.
European journal of pharmacology 2003;478(2-3):131-7.
2003: Kristof Deseure; Wouter Koek; Hugo Adriaensen; Francis C Colpaert
Continuous administration of the 5-hydroxytryptamine1A agonist (3-Chloro-4-fluoro-phenyl)-[4-fluoro-4-[[(5-methyl-pyridin-2-ylmethyl) -amino]-methyl]piperidin-1-yl]-methadone (F 13640) attenuates allodynia-like behavior in a rat model of trigeminal neuropathic pain.
The Journal of pharmacology and experimental therapeutics 2003;306(2):505-14.
2003: Thierry Wurch; Francis C Colpaert; Petrus J Pauwels
Mutation in a protein kinase C phosphorylation site of the 5-HT1A receptor preferentially attenuates Ca2+ responses to partial as opposed to higher-efficacy 5-HT1A agonists.
Neuropharmacology 2003;44(7):873-81.
2003: Robert Letienne; Yvan Verscheure; Michel Perez; Bruno Le Grand; Francis C Colpaert; Gareth W John
Donitriptan selectively decreases jugular venous oxygen saturation in the anesthetized pig: further insights into its mechanism of action relevant to headache relief.
The Journal of pharmacology and experimental therapeutics 2003;305(2):749-54.
2003: Liesbeth A Bruins Slot; Wouter Koek; Jean-Pierre Tarayre; Francis C Colpaert
Tolerance and inverse tolerance to the hyperalgesic and analgesic actions, respectively, of the novel analgesic, F 13640.
European journal of pharmacology 2003;466(3):271-9.
2003: Francis C Colpaert
Discovering risperidone: the LSD model of psychopathology.
Nature reviews. Drug discovery 2003;2(4):315-20.
2003: Laurent Bardin; Jean-Pierre Tarayre; N Malfetes; Wouter Koek; Francis C Colpaert
Profound, non-opioid analgesia produced by the high-efficacy 5-HT(1A) agonist F 13640 in the formalin model of tonic nociceptive pain.
Pharmacology 2003;67(4):182-94.
2003: Liesbeth A Bruins Slot; Francis C Colpaert
A persistent opioid-addiction state of memory.
Behavioural pharmacology 2003;14(2):167-71.
2003: Liesbeth A Bruins Slot; Philippe Chopin; Francis C Colpaert
Tacrine-scopolamine interactions on state-dependent retrieval.
Psychopharmacology 2003;166(1):33-9.
2003: Thierry Wurch; Elisa A Boutet-Robinet; Christiane Palmier; Francis C Colpaert; Petrus J Pauwels
Constitutive coupling of a chimeric dopamine D2/alpha 1B receptor to the phospholipase C pathway: inverse agonism to silent antagonism by neuroleptic drugs.
The Journal of pharmacology and experimental therapeutics 2003;304(1):380-90.
2002: Kristof Deseure; Wouter Koek; Francis C Colpaert; Hugo Adriaensen
The 5-HT(1A) receptor agonist F 13640 attenuates mechanical allodynia in a rat model of trigeminal neuropathic pain.
European journal of pharmacology 2002;456(1-3):51-7.
2002: Francis C Colpaert; Jean-Pierre Tarayre; Wouter Koek; Petrus J Pauwels; Laurent Bardin; X-J Xu; Z Wiesenfeld-Hallin; Cristina Cosi; Elisabeth Carilla-Durand; Marie-Bernadette Assié; Bernard Vacher
Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesia.
Neuropharmacology 2002;43(6):945-58.
2002: Eric P M Prinssen; Francis C Colpaert; Wouter Koek
5-HT1A receptor activation and anti-cataleptic effects: high-efficacy agonists maximally inhibit haloperidol-induced catalepsy.
European journal of pharmacology 2002;453(2-3):217-21.
2002: Liesbeth A Bruins Slot; Jean-Pierre Tarayre; Wouter Koek; Jean-Paul Ribet; Francis C Colpaert
Experimental conditions for the continuous subcutaneous infusion of four central analgesics in rats.
Pharmacology, biochemistry, and behavior 2002;72(4):943-51.
2002: Petrus J Pauwels; Isabelle Rauly; Thierry Wurch; Francis C Colpaert
Evidence for protean agonism of RX 831003 at alpha 2A-adrenoceptors by co-expression with different G alpha protein subunits.
Neuropharmacology 2002;42(6):855-63.
2002: Philippe Chopin; Francis C Colpaert; Marc Marien
Effects of acute and subchronic administration of dexefaroxan, an alpha(2)-adrenoceptor antagonist, on memory performance in young adult and aged rodents.
The Journal of pharmacology and experimental therapeutics 2002;301(1):187-96.
2002: Liesbeth A Bruins Slot; P J Pauwels; Francis C Colpaert
Sign-reversal during persistent activation in mu-opioid signal transduction.
Journal of theoretical biology 2002;215(2):169-82.
2002: Yves Rival; Nathalie Benéteau; Thierry Taillandier; Mylène Pezet; Elisabeth Dupont-Passelaigue; Jean-François Patoiseau; Didier Junquéro; Francis C Colpaert; André Delhon
PPARalpha and PPARdelta activators inhibit cytokine-induced nuclear translocation of NF-kappaB and expression of VCAM-1 in EAhy926 endothelial cells.
European journal of pharmacology 2002;435(2-3):143-51.
2001: Francis C Colpaert; Wouter Koek; Liesbeth A Bruins Slot
Evidence that mnesic states govern normal and disordered memory.
Behavioural pharmacology 2001;12(8):575-89.
2001: Petrus J Pauwels; Stéphanie Tardif; Francis C Colpaert
Differential signalling of both wild-type and Thr(343)Arg dopamine D(2short) receptor by partial agonists in a G-protein-dependent manner.
Biochemical pharmacology 2001;62(6):723-32.
2001: Petrus J Pauwels; Stéphanie Tardif; Thierry Wurch; Francis C Colpaert
Real-time analysis of dopamine: antagonist interactions at recombinant human D2long receptor upon modulation of its activation state.
British journal of pharmacology 2001;134(1):88-97.
2001: Laurent Bardin; Jean-Pierre Tarayre; Wouter Koek; Francis C Colpaert
In the formalin model of tonic nociceptive pain, 8-OH-DPAT produces 5-HT1A receptor-mediated, behaviorally specific analgesia.
European journal of pharmacology 2001;421(2):109-14.
2001: Wouter Koek; Bernard Vacher; Cristina Cosi; Marie-Bernadette Assié; Jean-François Patoiseau; Petrus J Pauwels; Francis C Colpaert
5-HT1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential.
European journal of pharmacology 2001;420(2-3):103-12.
2001: Petrus J Pauwels; Thierry Wurch; Stéphanie Tardif; Frederic FINANA; Francis C Colpaert
Analysis of ligand activation of alpha 2-adrenoceptor subtypes under conditions of equal G alpha protein stoichiometry.
Naunyn-Schmiedeberg's archives of pharmacology 2001;363(5):526-36.
2001: Petrus J Pauwels; Stéphanie Tardif; Francis C Colpaert; Thierry Wurch
Modulation of ligand responses by coupling of alpha(2A)-adrenoceptors to diverse G(alpha)-proteins.
Biochemical pharmacology 2001;61(9):1079-92.
2001: Petrus J Pauwels; Frederic FINANA; Stéphanie Tardif; Thierry Wurch; Francis C Colpaert
Dynamic dopamine-antagonist interactions at recombinant human dopamine D(2short) receptor: dopamine-bound versus antagonist-bound receptor states.
The Journal of pharmacology and experimental therapeutics 2001;297(1):133-40.
2001: Francis C Colpaert; Jean-Pierre Tarayre; M Alliaga; Liesbeth A Bruins Slot; N Attal; Wouter Koek
Opiate self-administration as a measure of chronic nociceptive pain in arthritic rats.
Pain 2001;91(1-2):33-45.
2001: Didier Junquero; F Bruniquel; X N'Guyen; JM Autin; Jean-François Patoiseau; Anne-D Degryse; Francis C Colpaert; André Delhon
F 12511, a novel ACAT inhibitor, and atorvastatin regulate endogenous hypercholesterolemia in a synergistic manner in New Zealand rabbits fed a casein-enriched diet.
Atherosclerosis 2001;155(1):131-42.
2001: Didier Junquero; Antoine Pilon; Elisabeth Carilla-Durand; Jean-François Patoiseau; Jean-Pierre Tarayre; Gérard Torpier; Bart Staels; Jean-Charles Fruchart; Francis C Colpaert; Véronique Clavey; André Delhon
Lack of toxic effects of F 12511, a novel potent inhibitor of acyl-coenzyme A: cholesterol O-acyltransferase, on human adrenocortical cells in culture.
Biochemical pharmacology 2001;61(4):387-98.
2001: Didier Junquero; P Oms; Elisabeth Carilla-Durand; JM Autin; Jean-Pierre Tarayre; Anne-D Degryse; Jean-François Patoiseau; Francis C Colpaert; André Delhon
Pharmacological profile of F 12511, (S)-2',3', 5'-trimethyl-4'-hydroxy-alpha-dodecylthioacetanilide a powerful and systemic acylcoenzyme A: cholesterol acyltransferase inhibitor.
Biochemical pharmacology 2001;61(1):97-108.
2001: DS Dupuis; Thierry Wurch; Stéphanie Tardif; Francis C Colpaert; Petrus J Pauwels
Modulation of 5-HT(1A) receptor activation by its interaction with wild-type and mutant g(alphai3) proteins.
Neuropharmacology 2001;40(1):36-47.
2000: Francis C Colpaert; Liesbeth A Bruins Slot; Wouter Koek; DS Dupuis
Memory of an operant response and of depressed mood retained in activation states of 5-HT(1A) receptors: evidence from rodent models.
Behavioural brain research 2000;117(1-2):41-51.
2000: Petrus J Pauwels; Francis C Colpaert
Partial to complete antagonism by putative antagonists at the wild-type alpha(2C)-adrenoceptor based on kinetic analyses of agonist:antagonist interactions.
British journal of pharmacology 2000;131(7):1385-90.
2000: Petrus J Pauwels; Francis C Colpaert
Heterogeneous ligand-mediated Ca(++) responses at wt and mutant alpha(2A)-adrenoceptors suggest multiple ligand activation binding sites at the alpha(2A)-adrenoceptor.
Neuropharmacology 2000;39(11):2101-11.
2000: Petrus J Pauwels; Francis C Colpaert
Disparate ligand-mediated Ca(2+) responses by wild-type, mutant Ser(200)Ala and Ser(204)Ala alpha(2A)-adrenoceptor: G(alpha15) fusion proteins: evidence for multiple ligand-activation binding sites.
British journal of pharmacology 2000;130(7):1505-12.
2000: Eric P M Prinssen; Wouter Koek; Francis C Colpaert; Mark S Kleven
Repeated treatment with 8-OH-DPAT induces tolerance to its ability to produce the 5-HT1A behavioural syndrome, but not to its ability to attenuate haloperidol-induced catalepsy.
Behavioural pharmacology 2000;11(3-4):299-305.
2000: Petrus J Pauwels; Frederic FINANA; Stéphanie Tardif; Francis C Colpaert; Thierry Wurch
Agonist efficacy at the alpha2A-adrenoceptor:G alpha15 fusion protein: an analysis based on Ca2+ responses.
Naunyn-Schmiedeberg's archives of pharmacology 2000;361(6):672-9.
2000: Petrus J Pauwels; Stéphanie Tardif; Thierry Wurch; Francis C Colpaert
Facilitation of constitutive alpha(2A)-adrenoceptor activity by both single amino acid mutation (Thr(373)Lys) and g(alphao) protein coexpression: evidence for inverse agonism.
The Journal of pharmacology and experimental therapeutics 2000;292(2):654-63.
2000: Petrus J Pauwels; Stéphanie Tardif; Frederic FINANA; Thierry Wurch; Francis C Colpaert
Ligand-receptor interactions as controlled by wild-type and mutant Thr(370)Lys alpha2B-adrenoceptor-Galpha15 fusion proteins.
Journal of neurochemistry 2000;74(1):375-84.
1999: Liesbeth A Bruins Slot; Francis C Colpaert
Opiate states of memory: receptor mechanisms.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1999;19(23):10520-9.
1999: Liesbeth A Bruins Slot; Pier Vincenzo Piazza; Francis C Colpaert
Neuroactive steroids and the constraint of memory.
The European journal of neuroscience 1999;11(11):4081-8.
1999: Liesbeth A Bruins Slot; Francis C Colpaert
Experimental realization of a signal transduction algorithm.
Journal of theoretical biology 1999;200(1):39-48.
1999: DS Dupuis; Stéphanie Tardif; Thierry Wurch; Francis C Colpaert; Petrus J Pauwels
Modulation of 5-HT1A receptor signalling by point-mutation of cysteine351 in the rat Galpha(o) protein.
Neuropharmacology 1999;38(7):1035-41.
1999: Gareth W John; Petrus J Pauwels; Michel Perez; Serge Halazy; Bruno Le Grand; Yvan Verscheure; JP Valentin; Christiane Palmier; Thierry Wurch; Philippe Chopin; Marc Marien; Mark S Kleven; Wouter Koek; M B Assie; Elisabeth Carilla-Durand; Jean-Pierre Tarayre; Francis C Colpaert
F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine.
The Journal of pharmacology and experimental therapeutics 1999;290(1):83-95.
1999: DS Dupuis; Michel Perez; Serge Halazy; Francis C Colpaert; Petrus J Pauwels
Magnitude of 5-HT1B and 5-HT1A receptor activation in guinea-pig and rat brain: evidence from sumatriptan dimer-mediated [35S]GTPgammaS binding responses.
Brain research. Molecular brain research 1999;67(1):107-23.
1999: Liesbeth A Bruins Slot; Francis C Colpaert
Recall rendered dependent on an opiate state.
Behavioral neuroscience 1999;113(2):337-44.
1999: Liesbeth A Bruins Slot; Wouter Koek; Francis C Colpaert
Ethanol state dependence involving a lever press response requirement in rats.
Behavioural pharmacology 1999;10(2):229-33.
1999: Thierry Wurch; Francis C Colpaert; Petrus J Pauwels
G-protein activation by putative antagonists at mutant Thr373Lys alpha2A adrenergic receptors.
British journal of pharmacology 1999;126(4):939-48.
1999: Philippe Chopin; Francis C Colpaert; Marc Marien
Effects of alpha-2 adrenoceptor agonists and antagonists on circling behavior in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway.
The Journal of pharmacology and experimental therapeutics 1999;288(2):798-804.
1998: Thierry Wurch; Francis C Colpaert; Petrus J Pauwels
Chimeric receptor analysis of the ketanserin binding site in the human 5-Hydroxytryptamine1D receptor: importance of the second extracellular loop and fifth transmembrane domain in antagonist binding.
Molecular pharmacology 1998;54(6):1088-96.
1998: Wouter Koek; Jean-François Patoiseau; Marie-Bernadette Assié; Cristina Cosi; Mark S Kleven; Elisabeth Dupont-Passelaigue; Elisabeth Carilla-Durand; Christiane Palmier; JP Valentin; G John; Petrus J Pauwels; Jean-Pierre Tarayre; Francis C Colpaert
F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potential.
The Journal of pharmacology and experimental therapeutics 1998;287(1):266-83.
1998: Petrus J Pauwels; Christiane Palmier; DS Dupuis; Francis C Colpaert
Interaction of 5-HT1B/D ligands with recombinant h 5-HT1A receptors: intrinsic activity and modulation by G-protein activation state.
Naunyn-Schmiedeberg's archives of pharmacology 1998;357(5):490-9.
1998: DS Dupuis; Francis C Colpaert; Petrus J Pauwels
G-protein activation at 5-HT1A receptors by the 5-ht1F ligand LY334370 in guinea-pig brain sections and recombinant cell lines.
British journal of pharmacology 1998;124(2):283-90.
1998: DS Dupuis; Christiane Palmier; Francis C Colpaert; Petrus J Pauwels
Autoradiography of serotonin 5-HT1A receptor-activated G proteins in guinea pig brain sections by agonist-stimulated [35S]GTPgammaS binding.
Journal of neurochemistry 1998;70(3):1258-68.
1998: F Pagniez; JP Valentin; S Vieu; Francis C Colpaert; Gareth W John
Pharmacological analysis of the haemodynamic effects of 5-HT1B/D receptor agonists in the normotensive rat.
British journal of pharmacology 1998;123(2):205-14.
1998: Petrus J Pauwels; Thierry Wurch; Christiane Palmier; Francis C Colpaert
Pharmacological analysis of G-protein activation mediated by guinea-pig recombinant 5-HT1B receptors in C6-glial cells: similarities with the human 5-HT1B receptor.
British journal of pharmacology 1998;123(1):51-62.
1997: Petrus J Pauwels; Stéphanie Tardif; Thierry Wurch; Francis C Colpaert
Stimulated [35S]GTP gamma S binding by 5-HT1A receptor agonists in recombinant cell lines. Modulation of apparent efficacy by G-protein activation state.
Naunyn-Schmiedeberg's archives of pharmacology 1997;356(5):551-61.
1997: F Bertolino; JP Valentin; Jean-François Patoiseau; J P Rieu; Francis C Colpaert; Gareth W John
Evidence for partial agonist properties of daltroban (BM 13,505) at TP receptors in the anaesthetized open-chest rat.
Naunyn-Schmiedeberg's archives of pharmacology 1997;356(4):462-6.
1997: Petrus J Pauwels; Stéphanie Tardif; Christiane Palmier; Thierry Wurch; Francis C Colpaert
How efficacious are 5-HT1B/D receptor ligands: an answer from GTP gamma S binding studies with stably transfected C6-glial cell lines.
Neuropharmacology 1997;36(4-5):499-512.
1997: Thierry Wurch; Christiane Palmier; Francis C Colpaert; Petrus J Pauwels
Recombinant saphenous vein 5-HT1B receptors of the rabbit: comparative pharmacology with human 5-HT1B receptors.
British journal of pharmacology 1997;120(1):153-9.
1997: Thierry Wurch; Christiane Palmier; Francis C Colpaert; Petrus J Pauwels
Sequence and functional analysis of cloned guinea pig and rat serotonin 5-HT1D receptors: common pharmacological features within the 5-HT1D receptor subfamily.
Journal of neurochemistry 1997;68(1):410-8.